396 related articles for article (PubMed ID: 21904456)
21. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
Maeda N; Takeuchi Y; Takada M; Sadzuka Y; Namba Y; Oku N
J Control Release; 2004 Nov; 100(1):41-52. PubMed ID: 15491809
[TBL] [Abstract][Full Text] [Related]
22. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
[TBL] [Abstract][Full Text] [Related]
23. Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice.
Kim WJ; Yockman JW; Jeong JH; Christensen LV; Lee M; Kim YH; Kim SW
J Control Release; 2006 Sep; 114(3):381-8. PubMed ID: 16884805
[TBL] [Abstract][Full Text] [Related]
24. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
25. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.
Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M
J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA.
Kim N; Jiang D; Jacobi AM; Lennox KA; Rose SD; Behlke MA; Salem AK
Int J Pharm; 2012 May; 427(1):123-33. PubMed ID: 21864664
[TBL] [Abstract][Full Text] [Related]
27. Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration.
Liang Y; Liu Z; Shuai X; Wang W; Liu J; Bi W; Wang C; Jing X; Liu Y; Tao E
Biochem Biophys Res Commun; 2012 May; 421(4):690-5. PubMed ID: 22542938
[TBL] [Abstract][Full Text] [Related]
28. Tyroserleutide-based gene vector for suppressing VEGF expression in cancer therapy.
Wang HY; Yi WJ; Qin SY; Li C; Zhuo RX; Zhang XZ
Biomaterials; 2012 Nov; 33(33):8685-94. PubMed ID: 22925816
[TBL] [Abstract][Full Text] [Related]
29. An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma.
Shen M; Gong F; Pang P; Zhu K; Meng X; Wu C; Wang J; Shan H; Shuai X
Int J Nanomedicine; 2012; 7():3319-32. PubMed ID: 22802690
[TBL] [Abstract][Full Text] [Related]
30. Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease.
Liu YY; Yang XY; Li Z; Liu ZL; Cheng D; Wang Y; Wen XJ; Hu JY; Liu J; Wang LM; Wang HJ
CNS Neurosci Ther; 2014 Jan; 20(1):76-85. PubMed ID: 24279586
[TBL] [Abstract][Full Text] [Related]
31. Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy.
Zhang M; Zhang M; Wang J; Cai Q; Zhao R; Yu Y; Tai H; Zhang X; Xu C
Drug Deliv; 2018 Nov; 25(1):995-1003. PubMed ID: 29667478
[TBL] [Abstract][Full Text] [Related]
32. A single-monomer derived linear-like PEI-co-PEG for siRNA delivery and silencing.
Tsai LR; Chen MH; Chien CT; Chen MK; Lin FS; Lin KM; Hwu YK; Yang CS; Lin SY
Biomaterials; 2011 May; 32(14):3647-53. PubMed ID: 21324524
[TBL] [Abstract][Full Text] [Related]
33. [Small interfering RNA delivery mediated by mPEG-PCL-g-PEI polymer nanoparticles].
Huang W; Lü M; Gao ZG; Jin MJ; Yang CQ
Yao Xue Xue Bao; 2011 Mar; 46(3):344-9. PubMed ID: 21626792
[TBL] [Abstract][Full Text] [Related]
34. Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.
Zhao Z; Li Y; Shukla R; Liu H; Jain A; Barve A; Cheng K
Theranostics; 2019; 9(15):4508-4524. PubMed ID: 31285776
[TBL] [Abstract][Full Text] [Related]
35. Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.
Wang G; Gao X; Gu G; Shao Z; Li M; Wang P; Yang J; Cai X; Li Y
Int J Nanomedicine; 2017; 12():3591-3603. PubMed ID: 28533682
[TBL] [Abstract][Full Text] [Related]
36. Cationic nano-copolymers mediated IKKbeta targeting siRNA inhibit the proliferation of human Tenon's capsule fibroblasts in vitro.
Duan Y; Guan X; Ge J; Quan D; Zhuo Y; Ye H; Shao T
Mol Vis; 2008; 14():2616-28. PubMed ID: 19137061
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.
Nie C; Liu C; Chen G; Dai J; Li H; Shuai X
J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388
[TBL] [Abstract][Full Text] [Related]
38. Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) copolymers.
Zheng M; Librizzi D; Kılıç A; Liu Y; Renz H; Merkel OM; Kissel T
Biomaterials; 2012 Sep; 33(27):6551-8. PubMed ID: 22710127
[TBL] [Abstract][Full Text] [Related]
39. Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer.
Chen Y; Wang W; Lian G; Qian C; Wang L; Zeng L; Liao C; Liang B; Huang B; Huang K; Shuai X
Int J Nanomedicine; 2012; 7():359-68. PubMed ID: 22848158
[TBL] [Abstract][Full Text] [Related]
40. Engineering biodegradable micelles of polyethylenimine-based amphiphilic block copolymers for efficient DNA and siRNA delivery.
Wang W; Balk M; Deng Z; Wischke C; Gossen M; Behl M; Ma N; Lendlein A
J Control Release; 2016 Nov; 242():71-79. PubMed ID: 27498020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]